Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Failure rate and "professional subjects" in clinical trials of major depressive disorder.

Literature DB >> 21951988

Failure rate and "professional subjects" in clinical trials of major depressive disorder.

Thomas M Shiovitz, Marlene E Zarrow, Andrew M Shiovitz, Alexander M Bystritsky.

Abstract

Entities: Disease

Mesh：

Substances：
Antidepressive Agents

Year: 2011 PMID： 21951988 DOI： 10.4088/JCP.11lr07229

Source DB: PubMed Journal: J Clin Psychiatry ISSN： 0160-6689 Impact factor: 4.384

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

Review 1. Deception in clinical trials and its impact on recruitment and adherence of study participants.

Authors: Chuen Peng Lee; Tyson Holmes; Eric Neri; Clete A Kushida
Journal: Contemp Clin Trials Date: 2018-08-21 Impact factor: 2.226

Review 2. Conducting clinical research in community mental health settings: Opportunities and challenges.

Authors: Oleg V Tcheremissine; Whitney E Rossman; Manuel A Castro; Dineen R Gardner
Journal: World J Psychiatry Date: 2014-09-22

3. Safety, Science, or Both? Deceptive Healthy Volunteers: Psychiatric Conditions Uncovered by Objective Methods of Screening.

Authors: Adriana Pavletic; Maryland Pao
Journal: Psychosomatics Date: 2017-05-09 Impact factor: 2.386

Review 4. Methods to reduce the incidence of false negative trial results in substance use treatment research.

Authors: Rachel L Tomko; Erin A McClure; Lindsay M Squeglia; Hayley Treloar Padovano; Aimee L McRae-Clark; Nathaniel L Baker; Matthew J Carpenter; Kevin M Gray
Journal: Curr Opin Psychol Date: 2019-01-28

5. CNS sites cooperate to detect duplicate subjects with a clinical trial subject registry.

Authors: Thomas M Shiovitz; Charles S Wilcox; Lilit Gevorgyan; Adnan Shawkat
Journal: Innov Clin Neurosci Date: 2013-02

Review 6. Medication Nonadherence, "Professional Subjects," and Apparent Placebo Responders: Overlapping Challenges for Medications Development.

Authors: David J McCann; Nancy M Petry; Anders Bresell; Eva Isacsson; Ellis Wilson; Robert C Alexander
Journal: J Clin Psychopharmacol Date: 2015-10 Impact factor: 3.153

Failure rate and "professional subjects" in clinical trials of major depressive disorder.

Review 1. Deception in clinical trials and its impact on recruitment and adherence of study participants.

Review 2. Conducting clinical research in community mental health settings: Opportunities and challenges.

3. Safety, Science, or Both? Deceptive Healthy Volunteers: Psychiatric Conditions Uncovered by Objective Methods of Screening.

Review 4. Methods to reduce the incidence of false negative trial results in substance use treatment research.

5. CNS sites cooperate to detect duplicate subjects with a clinical trial subject registry.

Review 6. Medication Nonadherence, "Professional Subjects," and Apparent Placebo Responders: Overlapping Challenges for Medications Development.

7. Frequency of concealment, fabrication and falsification of study data by deceptive subjects.

8. (Non-) impact of task experience on behavioral economic decision-making.

9. Mitigating the Effects of Nonadherence in Clinical Trials.

10. Strategies to exclude subjects who conceal and fabricate information when enrolling in clinical trials.